Table of Contents Table of Contents
Previous Page  911 / 1851 Next Page
Information
Show Menu
Previous Page 911 / 1851 Next Page
Page Background

PCNSL [≤ 65 ys. + PS 0-3] or [65-70 ys. + PS ≤2]

®

®

WBRT 36 Gy

±

boost 9 Gy

BCNU 400 mg/m

2

d.1

Thiotepa 5 mg/Kg x 2/d; d.2-3

+ APBSCT

MTX 3.5 g/m

2

d.1

araC 2 g/m

2

x 2/d, d. 2-3

every 3 weeks

Rituximab 375 mg/m

2

d-5 & 0

MTX 3.5 g/m

2

d.1

araC 2 g/m

2

x 2/d, d. 2-3

every 3 weeks

Rituximab 375 mg/m

2

d-5 & 0

MTX 3.5 g/m

2

d.1

araC 2 g/m

2

x 2/d, d. 2-3

Thiotepa 30 mg/m

2

d.4

every 3 weeks

Response assessment

CR – PR - SD

PD – tox

SC harvest

WBRT 40 Gy

±

boost 9 Gy